Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Coffee has become more than just a pre-game boost for these current and retired NFL players. Their caffeine-fueled ventures prioritize quality and community.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果